Role of copper ion in the pathogenesis of type 2 diabetes

Endocrine Journal

Volumn 56, Issue 5, 2009, Pages 699-706

  Tanaka, Ayako ^a   Kaneto, Hideaki ^a   Miyatsuka, Takeshi ^a   Yamamoto, Kaoru ^a   Yoshiuchi, Kazutomi ^a   Yamasaki, Yoshimitsu ^a   Shimomura, Iichiro ^a   Matsuoka, Taka Aki ^a   Matsuhisa, Munehide ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Copper ion; Reactive oxygen species; Type 2 diabetes

Indexed keywords

CHELATING AGENT; COPPER; REACTIVE OXYGEN METABOLITE; TETRATHIOMOLYBDIC ACID;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FENTON REACTION; GLUCOSE INTOLERANCE; INSULIN RESISTANCE; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; BLOOD GLUCOSE; CHELATING AGENTS; COPPER; DIABETES MELLITUS, TYPE 2; LIPID METABOLISM; MALE; MICE; MICE, INBRED C57BL; MOLYBDENUM; REACTIVE OXYGEN SPECIES;

EID: 69249212349     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K09E-051     Document Type: Article

References (32)

1. Uriu-Adams JY, Keen CL (2005) Copper, oxidative stress, and human health. Mol Aspects Med 26: 268-298. (Pubitemid 41225353)
2. Goodman VL, Brewer GJ, Merajver SD (2005) Control of copper status for cancer therapy. Curr Cancer Drug Targets 7: 543-549. (Pubitemid 41502565)
3. Walshe JM (2007) Cause of death in Wilson disease. Mov Disord 22: 2216-2220.
4. Brewer GJ, Merajver SD (2002) Cancer therapy with tetrathiomolybdate: antiangiogenesis by lowering body copper. Integr Cancer Ther 1: 327-337.
5. Brewer GJ, Dick R, Zeng C, Hou G (2006) The use of tetrathiomolybdate in treating fibrotic, inflammatory, and autoimmune diseases, including the non-obese diabetic mouse model. J Inorg Biochem 100: 927-930.
6. Juarez JC, Betancourt Jr O, Pirie-Shepherd SR, Guan X, Price ML, Shaw DE, Mazar AP, Donate F (2006) Copper binding by tetrathiomolybdate attenuates angiogenesis and tumor cell proliferation through the inhibition of superoxide dismutase 1. Clin Cancer Res 12: 4974-4981. (Pubitemid 44338586)
7. McCubbin MD, Hou G, Abrams GD, Dick R, Zhang Z, Brewer GJ (2006) Tetrathiomolybdate is effective in a mouse model of arthritis. J Rheumatol 33: 2501-2506. (Pubitemid 46067832)
8. Song M, Song Z, Barve S, Zhang J, Chen T, Liu M, Arteel GE, Brewer GJ, McClain CJ (2008) Tetrathiomolybdate protects against bile duct ligation- induced cholestatic liver injury and fibrosis. J Pharmacol Exp Ther 325: 409-416. (Pubitemid 351574799)
9. G. Hou, G.D. Abrams, R. Dick, G.J. Brewer, Efficacy of tetrathiomolybdate in a mouse model of multiple sclerosis. Transl. Res. 152 (2008) 239-244.
10. Gong D, Lu J, Chen X, Reddy S, Crossman CJ, Glyn-Jones S, Choong YS, Kennedy J, Barry B, Zhang S, Chan YK, Ruggiero K, Phillips AR, Cooper GJ (2008) A copper (II)-selective chelator ameliorates diabetes- evoked renal fibrosis and albuminuria, and suppresses pathogenic TGF-beta activation in the kidneys of rats used as a model of diabetes. Diabetologia 51: 1741-1751.
11. Hunt JV, Smith CC, Wolff SP (1990) Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes 39: 1420-1424.
12. Kobayashi K, Watanabe J, Umeda F, Nawata H (1995) Glycation accelerates the oxidation of low density lipoprotein by copper ions. Endocr J 42: 461-465.
13. Masad A, Hayes L, Tabner BJ, Turnbull S, Cooper LJ, Fullwood NJ, German MJ, Kametani F, El-Agnaf OM, Allsop D (2007) Copper-mediated formation of hydrogen peroxide from the amylin peptide: A novel mechanism for degeneration of islet cells in type-2 diabetes mellitus? FEBS Lett 581: 3489-3493. (Pubitemid 47048200)
14. Dandona P, Thusu K, Cook S, Snyder B, Makowski J, Armstrong D, Nicotera T (1996) Oxidative damage to DNA in diabetes mellitus. Lancet 347: 444-445. (Pubitemid 26054071)
15. Ihara Y, Toyokuni S, Uchida K, Odaka H, Tanaka T, Ikeda H, Hiai H, Seino Y, Yamada Y (1999) Hyperglycemia causes oxidative stress in pancreatic β-cells of GK rats, a model of type 2 diabetes. Diabetes 48: 927-932. (Pubitemid 29153099)
16. Takahashi Y, Iida K, Takeno R, Kitazawa R, Kitazawa S, Kitamura H, Fujioka Y, Yamada H, Kanda F, Ohta S, Nishimaki K, Fujimoto M, Kondo T, Iguchi G, Takahashi K, Kaji H, Okimura Y, Chihara K (2008) Hepatic failure and enhanced oxidative stress in mitochondrial diabetes. Endocr J 55: 509-514. (Pubitemid 351949745)
17. Matsuoka T, Kajimoto Y, Watada H, Kaneto H, Kishimoto M, Umayahara Y, Fujitani Y, Kamada T, Kawamori R, Yamasaki Y (1997) Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells. J Clin Invest 99 144-150. (Pubitemid 27058305)
18. Rudich A, Tirosh A, Potashnik R, Hemi R, Kanety H, Bashan N (1998) Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes. Diabetes 47: 1562-1569. (Pubitemid 28445343)
19. Tanaka Y, Gleason CE, Tran POT, Harmon JS, Robertson RP (1999) Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc Natl Acad Sci USA 96: 10857-10862. (Pubitemid 29442234)
20. Tirosh A, Potashnik R, Bashan N, Rudich A (1999) Oxidative stress disrupts insulin-induced cellular redistribution of insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes: a putative cellular mechanism for impaired protein kinase B activation and GLUT4 translocation. J Biol Chem 274: 10595-10602. (Pubitemid 129518360)
21. Kaneto H, Xu G, Song KH, Suzuma K, Bonner-Weir S, SA, Weir GC (2001) Activation of the hexosamine pathway leads to deterioration of pancreatic β-cell function by provoking oxidative stress. J Biol Chem 276: 31099-31104. (Pubitemid 37384975)
22. Kaneto H, Xu G, Fujii N, Kim S, Bonner-Weir S, Weir GC (2002) Involvement of c-Jun n-terminal kinase in oxidative stress-mediated suppression of insulin gene expression. J Biol Chem 277: 30010-30018.
23. Evans JL, Goldfine ID, Maddux BA, Grodsky GM (2002) Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocrine Rev. 23: 599-622.
24. Kawamori D, Kajimoto Y, Kaneto H, Umayahara Y, Fujitani Y, Miyatsuka T, Watada H, Leibiger IB, Yamasaki Y, Hori M (2003) Oxidative stress induces nucleo-cytoplasmic translocation of pancreatic transcription factor PdX-1 through activation of c-Jun n-terminal kinase. Diabetes 52: 2896-2904. (Pubitemid 37466858)
25. Robertson RP (2004) Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 271: 42351-42354.
26. Wellen KE, Hotamisligil G (2005) Inflammation, stress, and diabetes. J Clin Invest 115: 1111-1119.
27. Kaneto H, Miyatsuka T, Kawamori D, Yamamoto K, Kato K, Shiraiwa T, Katakami N, Yamasaki Y, Matsuhisa M, Matsuoka TA (2008) PDX-1 and MafA play a crucial role in pancreatic β-cell differentiation and maintenance of mature β-cell function. Endocr J 55: 235-252. (Pubitemid 351670948)
28. Aramata S, Han SI, Kataoka K (2007) Roles and regulation of transcription factor MafA in islet β-cells. Endocr J 54: 656-666.
29. Kaneto H, Kajimoto Y, Miyagawa J, Matsuoka T, Fujitani Y, Umayahara Y, Hanafusa T, Matsuzawa Y, Yamasaki Y, Hori M (1999) Beneficial effects of antioxidants for diabetes: possible protection of pancreatic β-cells against glucose toxicity. Diabetes 48: 2398-2406. (Pubitemid 30395432)
30. Tanaka Y, Gleason CE, Tran POT, Harmon JS, Robertson RP (1999) Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc Natl Acad Sci USA 96: 10857-10862. (Pubitemid 29442234)
31. Haber CA, Lam TK, Yu Z, Gupta N, Goh T, Bogdanovic E, Giacca A, Fantus IG (2003) N-acetylcysteine and taurine prevent hyperglycemia-induced insulin resis tance in vivo: possible role of oxidative stress. Am J Physiol 285: E744-753. (Pubitemid 37176425)
32. Yamamoto M, Yamato E, Toyoda SI, Tashiro F, Ikegami H, Yodoi J, Miyazaki JI (2008) Transgenic expression of antioxidant protein thioredoxin in pancreatic beta cells prevents progression of type 2 diabetes mellitus. Antioxid Redox Signal 10: 43-49. (Pubitemid 350115982)